DRI Healthcare Trust
DRI Healthcare Trust (DHT-UN.TO) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for DRI Healthcare Trust (DHT-UN.TO), featuring income statements, balance sheets, and cash flow data.
DRI Healthcare Trust (DHT-UN.TO) Income Statement & Financial Overview
Access detailed annual and quarterly income data for DRI Healthcare Trust DHT-UN.TO financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $47.43M | $31.71M | $29.32M | $25.05M |
| Cost of Revenue | $17.25M | $0.00 | -$12.29M | $0.00 |
| Gross Profit | $30.17M | $31.71M | $41.60M | $25.05M |
| Gross Profit Ratio | $0.64 | $1.00 | $1.42 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.20M | $6.05M | $2.51M | $3.60M |
| Operating Expenses | $40.43M | $31.71M | $31.45M | $31.25M |
| Total Costs & Expenses | $40.43M | $31.71M | $30.14M | $31.25M |
| Interest Income | $382000.00 | $774000.00 | $577000.00 | $722000.00 |
| Interest Expense | $9.49M | $8.55M | $8.64M | $8.40M |
| Depreciation & Amortization | $25.31M | $26.10M | $25.64M | $25.09M |
| EBITDA | -$735040.00 | $0.00 | $31.55M | $0.00 |
| EBITDA Ratio | -$0.02 | $0.00 | $1.08 | $0.00 |
| Operating Income | $7.001M | $0.00 | -$20.60M | -$6.20M |
| Operating Income Ratio | $0.15 | $0.00 | -$0.70 | -$0.25 |
| Other Income/Expenses (Net) | $0.00 | -$1.69M | $18.47M | $8.51M |
| Income Before Tax | $7.001M | -$1.69M | -$2.13M | -$6.20M |
| Income Before Tax Ratio | $0.15 | -$0.05 | -$0.07 | -$0.25 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$18.78M |
| Net Income | $7.001M | -$1.69M | -$2.13M | -$6.20M |
| Net Income Ratio | $0.15 | -$0.05 | -$0.07 | -$0.25 |
| EPS | $0.12 | -$0.03 | -$0.04 | -$0.11 |
| Diluted EPS | $0.12 | -$0.03 | -$0.04 | -$0.11 |
| Weighted Avg Shares Outstanding | $39.11M | $56.29M | $53.33M | $56.36M |
| Weighted Avg Shares Outstanding (Diluted) | $39.39M | $56.29M | $56.43M | $56.36M |
Over the last four quarters, DRI Healthcare Trust's revenue moved from $25.05M in Q1 2024 to $47.43M in Q4 2024. Operating income in Q4 2024 was $7.001M, with a strong operating margin of 15%. Despite fluctuations in R&D and SG&A expenses, EBITDA for DRI Healthcare Trust remained robust at -$735040.00, reflecting operational efficiency. Net income rose to $7.001M, with an EPS of $0.12. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan